These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 30007243)

  • 61. Corrigendum to: Antipsychotics and severe hyponatremia: A Swedish population-based case-control study. Eur J Intern Med. 2019 Feb;60:71-77.
    Falhammar H; Lindh JD; Calissendorff J; Skov J; Nathanson D; Mannheimer B
    Eur J Intern Med; 2021 Oct; 92():142-143. PubMed ID: 34175184
    [No Abstract]   [Full Text] [Related]  

  • 62. Corrigendum to "ATP7B variant spectrum in a French pediatric Wilson disease cohort" [Eur. J. Med. Genet. 64 (10) (October 2021) 104305].
    Couchonnal E; Bouchard S; Sandahl TD; Pagan C; Lion-François L; Guillaud O; Habes D; Debray D; Lamireau T; Broué P; Fabre A; Vanlemmens C; Sobesky R; Gottrand F; Bridoux-Henno L; Belmalih A; Poujois A; Collet C; Francou B; Brunet AS; Lachaux A; Misrahi M; Bost M
    Eur J Med Genet; 2022 Mar; 65(3):104453. PubMed ID: 35183456
    [No Abstract]   [Full Text] [Related]  

  • 63. Corrigendum to: Associations of proton pump inhibitors and hospitalization due to hyponatremia: A population-based case-control study. Eur J Intern Med. 2019 Jan;59:65-69.
    Falhammar H; Lindh JD; Calissendorff J; Skov J; Nathanson D; Mannheimer B
    Eur J Intern Med; 2021 Sep; 91():107-108. PubMed ID: 34175185
    [No Abstract]   [Full Text] [Related]  

  • 64. Corrigendum to: Tramadol- and codeine-induced severe hyponatremia: A Swedish population-based case-control study. Eur J Intern Med. 2019 Nov;69:20-24.
    Falhammar H; Calissendorff J; Skov J; Nathanson D; Lindh JD; Mannheimer B
    Eur J Intern Med; 2021 Oct; 92():140-141. PubMed ID: 34172352
    [No Abstract]   [Full Text] [Related]  

  • 65. Optimization of small-molecule inhibitors of influenza virus polymerase: from thiophene-3-carboxamide to polyamido scaffolds.
    Lepri S; Nannetti G; Muratore G; Cruciani G; Ruzziconi R; Mercorelli B; Palù G; Loregian A; Goracci L
    J Med Chem; 2014 May; 57(10):4337-50. PubMed ID: 24785979
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Corrigendum to 'Targeting FGFR2 with alofanib (RPT835) shows potent activity in tumour models' [Eur J Cancer 61 (2016) 20-28].
    Tsimafeyeu I; Ludes-Meyers J; Stepanova E; Daeyaert F; Khochenkov D; Joose JB; Solomko E; Van Akene K; Peretolchina N; Yin W; Ryabaya O; Byakhov M; Tjulandin S
    Eur J Cancer; 2017 Jan; 70():156. PubMed ID: 27919550
    [No Abstract]   [Full Text] [Related]  

  • 67. Corrigendum to "Synthesis and biological evaluation of novel benzamide derivatives as potent smoothened antagonists" [Bioorg. Med. Chem. Lett. 24/5 (2014) 1426-1431].
    Wu TM; Wang DC; Xiang P; Zhang JN; Sang YX; Lin HJ; Chen J; Xie G; Song H; Zhao YL; Xie YM
    Bioorg Med Chem Lett; 2016 Sep; 26(18):4558. PubMed ID: 27542309
    [No Abstract]   [Full Text] [Related]  

  • 68. Corrigendum to "2-Arylthio-5-iodo pyrimidine derivatives as non-nucleoside HBV polymerase inhibitors" [Bioorg. Med. Chem. 26 (2018) 1573-1578].
    Wang J; Zhang L; Zhao J; Zhang Y; Liu Q; Tian C; Zhang Z; Liu J; Wang X
    Bioorg Med Chem; 2018 Jul; 26(13):3859. PubMed ID: 29929844
    [No Abstract]   [Full Text] [Related]  

  • 69. Corrigendum to "Evolvosides C-E, flavonol-4'-O-triglycosides from Evolvulus alsinoides and their anti-stress activity" [Bioorg. Med. Chem. 21 (2013) 1116-1122].
    Gupta P; Sharma U; Gupta P; Siripurapu KB; Maurya R
    Bioorg Med Chem; 2013 Apr; 21(8):2426. PubMed ID: 28689777
    [No Abstract]   [Full Text] [Related]  

  • 70. Screening for Novel Small-Molecule Inhibitors Targeting the Assembly of Influenza Virus Polymerase Complex by a Bimolecular Luminescence Complementation-Based Reporter System.
    Li C; Wang Z; Cao Y; Wang L; Ji J; Chen Z; Deng T; Jiang T; Cheng G; Qin FX
    J Virol; 2017 Mar; 91(5):. PubMed ID: 28031371
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Corrigendum to "Reengineered tricyclic anti-cancer agents" [Bioorg. Med. Chem. 23 (2015) 6528-6534].
    Kastrinsky DB; Sangodkar J; Zaware N; McClinch K; Farrington CC; Giannini HM; Izadmehr S; Dhawan NS; Narla G; Ohlmeyer M
    Bioorg Med Chem; 2015 Dec; 23(23):7487. PubMed ID: 28290285
    [No Abstract]   [Full Text] [Related]  

  • 72. Corrigendum to "Discovery of 4-aminopyrimidine analogs as highly potent dual P70S6K/Akt inhibitors" [Bioorgan. Med. Chem. Lett. 50 (2021) 128352].
    Xiao Y; Huck BR; Lan R; DeSelm L; Chen X; Qiu H; Neagu C; Johnson T; Mochalkin I; Gardberg A; Jiang X; Tian H; Dutt V; Santos D; Head J; Jackson J; Syed S; Lin J; Wilker E; Ma J; Clark A; Machl A; Bankston D; Jones CCV; Goutopoulos A; Sherer B
    Bioorg Med Chem Lett; 2022 Jul; 67():128758. PubMed ID: 35484006
    [No Abstract]   [Full Text] [Related]  

  • 73. Corrigendum to "Synthesis and biological evaluations of new nitric oxide-anti-inflammatory drug hybrids" [Bioorg Med Chem Lett (2017) 4358-4369].
    Abdelall EKA; Abdelhamid AO; Azouz AA
    Bioorg Med Chem Lett; 2018 Feb; 28(4):839. PubMed ID: 29395977
    [No Abstract]   [Full Text] [Related]  

  • 74. Corrigendum to "Synthesis and SAR of novel capsazepine analogs with significant anti-cancer effects in multiple cancer types" [Bioorg. Med. Chem. 27 (1) (2019) 208-215].
    De La Chapa J; Valdez M; Ruiz F; Gonzales K; Mitchell W; McHardy SF; Hart MJ; Polusani SR; Gonzales CB
    Bioorg Med Chem; 2019 Jun; 27(11):2280. PubMed ID: 31014563
    [No Abstract]   [Full Text] [Related]  

  • 75. Corrigendum to: Recent advances in the discovery of heparanase inhibitors as anti-cancer agents [Eur. J. Mech. 121 (2016) 209-220].
    Jia L; Ma S
    Eur J Med Chem; 2017 Jan; 125():793-794. PubMed ID: 27741490
    [No Abstract]   [Full Text] [Related]  

  • 76. A multidisciplinary study of 3-(β-d-glucopyranosyl)-5-substituted-1,2,4-triazole derivatives as glycogen phosphorylase inhibitors: Computation, synthesis, crystallography and kinetics reveal new potent inhibitors.
    Kun S; Begum J; Kyriakis E; Stamati ECV; Barkas TA; Szennyes E; Bokor É; Szabó KE; Stravodimos GA; Sipos Á; Docsa T; Gergely P; Moffatt C; Patraskaki MS; Kokolaki MC; Gkerdi A; Skamnaki VT; Leonidas DD; Somsák L; Hayes JM
    Eur J Med Chem; 2018 Mar; 147():266-278. PubMed ID: 29453094
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Microwave assisted synthesis and anti-influenza virus activity of 1-adamantyl substituted N-(1-thia-4-azaspiro[4.5]decan-4-yl)carboxamide derivatives.
    Göktaş F; Vanderlinden E; Naesens L; Cesur N; Cesur Z
    Bioorg Med Chem; 2012 Dec; 20(24):7155-9. PubMed ID: 23117173
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Corrigendum to "Novel salicylanilides from 4,5-dihalogenated salicylic acids: Synthesis, antimicrobial activity and cytotoxicity" [Bioorg. Med. Chem. 25 (2017) 1524-1532].
    Paraskevopoulos G; Monteiro S; Vosátka R; Krátký M; Navrátilová L; Trejtnar F; Stolaříková J; Vinšová J
    Bioorg Med Chem; 2017 Apr; 25(8):2530. PubMed ID: 28285926
    [No Abstract]   [Full Text] [Related]  

  • 79. Proteasome activation as a novel anti-aging strategy.
    Gonos E
    Free Radic Biol Med; 2014 Oct; 75 Suppl 1():S7. PubMed ID: 26461417
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Corrigendum to "Synthesis and biological activity of 2,5-diaryl-3-methylpyrimido[4,5-c]quinolin-1(2H)-one derivatives" [Bioorg. Med. Chem. 15 (2007) 2434-2440].
    Metwally K; Aly O; Aly E; Banerjee A; Ravindra R; Bane S
    Bioorg Med Chem; 2017 May; 25(9):2679. PubMed ID: 28341404
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.